Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
基本信息
- 批准号:9250425
- 负责人:
- 金额:$ 28.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-15 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is one of the most common liver diseases in the United States and a major cause of chronic liver failure and mortality. The mechanisms of liver injury in ALD remain unclear and as a result there is no proven therapy for this disease. Critical to the development of ALD is an overactive hepatic innate immune response. Activated resident Kupffer cells and recruited macrophages generate soluble factors that lead to steatosis, hepatocellular injury and fibrosis. Recent findings indicat that alcohol promotes proinflammatory M1 rather than anti-inflammatory M2 macrophage polarization. Our prior investigations have identified novel functions for the lysosomal, degradative pathway of autophagy in the regulation of cellular signaling pathways and lipid metabolism that mediate M1 and M2 macrophage polarization. The objective of this proposal is to delineate mechanisms by which autophagy regulates macrophage polarization and the hepatic injury that occurs as the result of the overactive proinflammatory response in ALD. Preliminary findings demonstrate that steatosis and hepatotoxins inhibit macrophage autophagy, and that alcohol and impaired autophagy act in concert to block M2 macrophage polarization. In addition, we have generated macrophage- specific mouse knockouts of autophagy and shown that they are sensitized to the development of a proinflammatory response and liver injury from lipopolysaccharide. Based on these and other preliminary studies, our central hypothesis is that alcohol impairs macrophage autophagy which promotes proinflammatory macrophage polarization and activation leading to an overactive innate immune response and ALD. We will test this hypothesis in studies contained in three Specific Aims that will delineate the mechanism by which macrophage autophagy is decreased by alcohol, and how this effect alters macrophage polarization and the generation of the hepatic innate immune response. First, we will test the hypothesis that alcohol decreases autophagic function in macrophages by inhibiting AMP-activated protein kinase signaling. Second, we will test the hypothesis that an alcohol-induced defect in autophagy promotes M1 and inhibits M2 macrophage polarization through effects on ER stress and mitochondrial beta-oxidation. Third, we will test the hypothesis that decreased autophagy in macrophages in vivo promotes ALD development by leading to an unrestrained proinflammatory immune response. The objective of these studies is to delineate novel paradigms by which the lysosomal pathway of autophagy regulates the hepatic proinflammatory innate immune response to alcohol. The ultimate goal of these investigations is to better understand the basic cellular mechanisms underlying the development of liver injury from alcohol in order to design new strategies to prevent and treat human ALD.
描述(申请人提供):酒精性肝病(ALD)是美国最常见的肝病之一,也是慢性肝功能衰竭和死亡的主要原因。ALD的肝损伤机制尚不清楚,因此目前还没有针对这种疾病的有效治疗方法。ALD发展的关键是过度活跃的肝脏天然免疫反应。激活的常驻Kupffer细胞和招募的巨噬细胞产生导致脂肪变性、肝细胞损伤和纤维化的可溶性因子。最近的发现表明,酒精促进促炎的M1而不是抗炎的M2巨噬细胞极化。我们先前的研究已经确定了自噬的溶酶体降解途径在调节细胞信号通路和介导M1和M2巨噬细胞极化的脂代谢中的新功能。这项建议的目的是描述自噬调节巨噬细胞极化的机制,以及由于ALD过度活跃的促炎反应而导致的肝损伤。初步研究结果表明,脂肪变性和肝毒素抑制巨噬细胞自噬,酒精和受损的自噬共同作用于阻断M2巨噬细胞极化。此外,我们还产生了巨噬细胞特异性的自噬敲除,并表明它们对内毒素引起的促炎反应和肝损伤具有敏感度。基于这些和其他初步研究,我们的中心假设是酒精损害巨噬细胞的自噬,促进促炎巨噬细胞的极化和激活,导致过度活跃的先天免疫反应和ALD。我们将在三个特定目标的研究中检验这一假设,这些研究将描绘酒精减少巨噬细胞自噬的机制,以及这种影响如何改变巨噬细胞极化和肝脏固有免疫反应的产生。首先,我们将验证酒精通过抑制AMP激活的蛋白激酶信号而降低巨噬细胞自噬功能的假设。其次,我们将检验酒精诱导的自噬缺陷通过对内质网应激和线粒体β-氧化的影响促进M1并抑制M2巨噬细胞极化的假设。第三,我们将检验这一假设,即体内巨噬细胞自噬减少通过导致不受抑制的促炎免疫反应来促进ALD的发展。这些研究的目的是描绘新的范例,通过自噬的溶酶体途径调节肝脏对酒精的促炎性先天免疫反应。这些研究的最终目的是为了更好地了解酒精引起肝损伤的基本细胞机制,以便设计新的策略来预防和治疗人类酒精性肝病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark J Czaja其他文献
Mark J Czaja的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark J Czaja', 18)}}的其他基金
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
连接粘附分子-A 和肠道通透性的缺陷:驱动非酒精性脂肪性肝炎的新机制的鉴定
- 批准号:
9913994 - 财政年份:2017
- 资助金额:
$ 28.41万 - 项目类别:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝的肝损伤机制
- 批准号:
9270797 - 财政年份:2016
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
- 批准号:
9115457 - 财政年份:2016
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
- 批准号:
9321316 - 财政年份:2016
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
- 批准号:
8785146 - 财政年份:2014
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
- 批准号:
9135052 - 财政年份:2014
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of the innate immune response in alcoholic liver disease by autophagy
通过自噬调节酒精性肝病的先天免疫反应
- 批准号:
8923124 - 财政年份:2014
- 资助金额:
$ 28.41万 - 项目类别:
Role of CYP2E1 in the Progression to NASH
CYP2E1 在 NASH 进展中的作用
- 批准号:
6744719 - 财政年份:2002
- 资助金额:
$ 28.41万 - 项目类别:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝的肝损伤机制
- 批准号:
8697041 - 财政年份:2002
- 资助金额:
$ 28.41万 - 项目类别:
相似国自然基金
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
- 批准号:82372202
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Innate-likeB细胞受损介导凋亡细胞的清除障碍在系统性红斑狼疮发病中的作用及机制研究
- 批准号:81860295
- 批准年份:2018
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
控制肠道病毒71型感染的先天性免疫保护机制及其应用
- 批准号:31270951
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
- 批准号:81171510
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
- 批准号:31170826
- 批准年份:2011
- 资助金额:70.0 万元
- 项目类别:面上项目
干扰素刺激基因2',3'环核苷酸磷酸二酯酶(CNP)抗病毒特性的研究
- 批准号:31170853
- 批准年份:2011
- 资助金额:56.0 万元
- 项目类别:面上项目
转录因子IRF3的泛素和SUMO修饰调节机制及其在抗病毒天然免疫中的功能
- 批准号:31130020
- 批准年份:2011
- 资助金额:315.0 万元
- 项目类别:重点项目
细胞内受体TLR9、NOD1和NOD2在不可分型流感嗜血杆菌肺组织感染中的作用
- 批准号:30670929
- 批准年份:2006
- 资助金额:27.0 万元
- 项目类别:面上项目
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Operating Grants
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
- 批准号:
10537391 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
- 批准号:
10667802 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
- 批准号:
10625948 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Innate immune regulation of lung inflammation through mitochondrial dynamics
通过线粒体动力学调节肺部炎症的先天免疫
- 批准号:
10659953 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Translational Regulation of SARS-CoV-2 in response to viral S protein-induced signaling
SARS-CoV-2 响应病毒 S 蛋白诱导信号传导的翻译调控
- 批准号:
10721101 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration
代谢和表观遗传调控是转分化和血管再生的结合体
- 批准号:
10905167 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
- 批准号:
494926 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Operating Grants
Regulation of Overall Cell Numbers During Epithelial Tissue Homeostasis and Pathogenesis
上皮组织稳态和发病机制中总细胞数量的调节
- 批准号:
10621985 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Role of cGAS-STING in cardiomyocyte cell cycle regulation
cGAS-STING 在心肌细胞周期调节中的作用
- 批准号:
10625952 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别: